FIELD: medicine.
SUBSTANCE: invention relates to field of biochemistry, in particular to set of oligonucleotide probes for diagnostics of human population, living on RF territory, for hereditary monogenic diseases, by detection of mutations and/or polymorphisms. Also claimed are method of obtaining DNA-microchip, set for research of population of people, as well as method of detection of associated with monogenic diseases mutations and/or polymorphisms, in which claimed set of oligonucleotide probes is applied.
EFFECT: invention makes it possible to increase self-descriptiveness, accuracy and reduce research term.
4 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULTANEOUS DIAGNOSIS OF HEREDITARY DISEASES | 2015 |
|
RU2627115C2 |
| METHOD FOR IDENTIFYING MUCOVISCIDOSIS CAUSING MUTATIONS IN CFTR HUMAN GENE, KIT OF PRIMERS, BIOCHIP, KIT OF TARGETS AND TEST SYSTEMS USED IN METHOD | 2012 |
|
RU2529717C2 |
| METHOD FOR PREDICTION OF POPULATION BIOTRANSFORMATION DISORDERS OF FOREIGN SUBSTANCES CAUSED BY EXPOSURE TO MAN-INDUCED CHEMICAL HABITAT FACTORS | 2012 |
|
RU2497120C1 |
| METHOD FOR PREDICTING THE RISK OF A SKIN PATHOLOGY IN THE FORM OF MELANOSIS OR DYSCHROMIA ASSOCIATED WITH EXCESSIVE ARSENIC CONTAMINATION IN A HUMAN | 2019 |
|
RU2714325C1 |
| METHOD FOR DIFFERENTIAL AND CONFIRMING MOLECULAR GENETIC DIAGNOSIS OF SENSORINEURAL HEARING LOSS IN A POPULATION OF CHUVASH | 2021 |
|
RU2768033C1 |
| DETERMINATION OF CANCER SUSCEPTIBILITY BY IDENTIFICATION OF GENOTYPIC COMBINATIONS OF SPECIFIC VERSIONS OF CYP1B1, BRCA2 AND CHEK2 GENES | 2006 |
|
RU2470998C2 |
| METHOD OF DETECTING DISORDERS OF PHYSIOLOGICAL IMMUNOSUPPRESSION IN CHILDREN IN FIRST GENERATION THROUGH PARENTAL LINEAGE WITH HEREDITARY TAINTED IN CONDITIONS OF ALUMINUM EXCESSIVE EXPOSURE | 2017 |
|
RU2655658C1 |
| METHOD OF GENETIC POLYMORPHISM ANALYSIS FOR CARRYING OUT POSTNATAL DNA-DIAGNOSTICS OF MUCOVISCIDOSIS | 2008 |
|
RU2412247C2 |
| METHOD FOR PREDICTION OF RISK OF MALIGNANT DISEASES OF MAMMARY GLAND AND/OR OVARIES IN PATIENTS AFTER KIDNEY TRANSPLANTATION | 2023 |
|
RU2821583C1 |
| METHOD FOR DIAGNOSING MUTATION C.-23+1G>A (RS80338940) OF THE GJB2 GENE | 2020 |
|
RU2746055C1 |
